Literature DB >> 11389696

Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles.

K Stubenrauch1, S Gleiter, U Brinkmann, R Rudolph, H Lilie.   

Abstract

The development of cell-type-specific delivery systems is highly desirable for gene-therapeutic applications. Current virus-based vector systems show broad cell specificity, which results in the need to restrict the natural tropism of these viral systems. Here we demonstrate that tumour-cell-specific virus-like particles can be functionally assembled in vitro from recombinant viral coat protein expressed in Escherichia coli. The insertion of a negatively charged peptide in the HI loop of polyoma VP1 interferes with the binding of VP1 to the natural recognition site on mammalian cells and also serves as an adapter for the coupling of antibody fragments that contain complementary charged fusion peptides. A recombinant antibody fragment of the tumour-specific anti-(Lewis Y) antibody B3 could be coupled to the mutant VP1 by engineered polyionic peptides and an additional disulphide bond. With this system an entirely recombinant cell-specific delivery system assembled in vitro could be generated that transfers genes preferentially to cells presenting the tumour-specific antigen on the cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389696      PMCID: PMC1221915          DOI: 10.1042/0264-6021:3560867

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1.

Authors:  R B Moreland; L Montross; R L Garcea
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.

Authors:  F Martin; J Kupsch; Y Takeuchi; S Russell; F L Cosset; M Collins
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

Review 3.  New protein engineering approaches to multivalent and bispecific antibody fragments.

Authors:  A Plückthun; P Pack
Journal:  Immunotechnology       Date:  1997-06

4.  Retrovirus vectors displaying the IgG-binding domain of protein A.

Authors:  K Ohno; D Meruelo
Journal:  Biochem Mol Med       Date:  1997-10

5.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment.

Authors:  T Stehle; Y Yan; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

6.  Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.

Authors:  P Pack; A Plückthun
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

7.  Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies.

Authors:  A Jiang; T H Chu; F Nocken; K Cichutek; R Dornburg
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells.

Authors:  J Forstová; N Krauzewicz; V Sandig; J Elliott; Z Palková; M Strauss; B E Griffin
Journal:  Hum Gene Ther       Date:  1995-03       Impact factor: 5.695

9.  Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.

Authors:  L H Pai; J K Batra; D J FitzGerald; M C Willingham; I Pastan
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 13.312

10.  A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.

Authors:  U Brinkmann; Y Reiter; S H Jung; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 12.779

View more
  10 in total

1.  Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.

Authors:  Young C Shin; William R Folk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles.

Authors:  Sharmila Pejawar-Gaddy; Yogendra Rajawat; Zoe Hilioti; Jia Xue; Daniel F Gaddy; Olivera J Finn; Raphael P Viscidi; Ioannis Bossis
Journal:  Cancer Immunol Immunother       Date:  2010-07-21       Impact factor: 6.968

3.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

4.  Listeriolysin O as cytotoxic component of an immunotoxin.

Authors:  Sabine Bergelt; Stefan Frost; Hauke Lilie
Journal:  Protein Sci       Date:  2009-06       Impact factor: 6.725

Review 5.  Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases.

Authors:  Zhengqiu Zhou; Grant L Austin; Robert Shaffer; Dustin D Armstrong; Matthew S Gentry
Journal:  Trends Mol Med       Date:  2019-09-12       Impact factor: 11.951

Review 6.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 7.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

8.  Quantum dot-induced viral capsid assembling in dissociation buffer.

Authors:  Ding Gao; Zhi-Ping Zhang; Feng Li; Dong Men; Jiao-Yu Deng; Hong-Ping Wei; Xian-En Zhang; Zong-Qiang Cui
Journal:  Int J Nanomedicine       Date:  2013-06-05

Review 9.  Intracellular targeting with engineered proteins.

Authors:  Shane Miersch; Sachdev S Sidhu
Journal:  F1000Res       Date:  2016-08-10

Review 10.  New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.

Authors:  Karl D Brune; Mark Howarth
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.